These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34482601)

  • 1. Associations among vascular risk factors, neuroimaging biomarkers, and cognition: Preliminary analyses from the Multi-Ethnic Study of Atherosclerosis (MESA).
    Lockhart SN; Schaich CL; Craft S; Sachs BC; Rapp SR; Jung Y; Whitlow CT; Solingapuram Sai KK; Cleveland M; Williams BJ; Burke GL; Bertoni A; Hayden KM; Hughes TM
    Alzheimers Dement; 2022 Apr; 18(4):551-560. PubMed ID: 34482601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of fractal dimension and other retinal vascular network parameters with cognitive performance and neuroimaging biomarkers: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Ong SS; Peavey JJ; Hiatt KD; Whitlow CT; Sappington RM; Thompson AC; Lockhart SN; Chen H; Craft S; Rapp SR; Fitzpatrick AL; Heckbert SR; Luchsinger JA; Klein BEK; Meuer SM; Cotch MF; Wong TY; Hughes TM
    Alzheimers Dement; 2024 Feb; 20(2):941-953. PubMed ID: 37828734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain Imaging Features Associated with 20-Year Cognitive Decline in a Community-Based Multiethnic Cohort without Dementia.
    Orlando A; Sharrett AR; Schneider ALC; Gottesman RF; Knopman DS; Rawlings A; Mosley TH; Jack CR; Wong D; Pike JR; Coresh J
    Neuroepidemiology; 2022; 56(3):183-191. PubMed ID: 35500554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Framingham Stroke Risk Profile Score and White Matter Disease Progression.
    Youssef H; Demirer M; Middlebrooks EH; Anisetti B; Meschia JF; Lin MP
    Neurologist; 2024 Jun; ():. PubMed ID: 38867496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrating Neuroimaging Measures in Nursing Research.
    Figuracion KCF; Thompson H; Mac Donald CL
    Biol Res Nurs; 2023 Jul; 25(3):341-352. PubMed ID: 36398659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the link between brain topological resilience and cognitive performance in the context of aging and vascular risk factors: A cross-ethnicity population-based study.
    Liu H; Jing J; Jiang J; Wen W; Zhu W; Li Z; Pan Y; Cai X; Liu C; Zhou Y; Meng X; Wang Y; Li H; Jiang Y; Zheng H; Wang S; Niu H; Kochan N; Brodaty H; Wei T; Sachdev PS; Fan Y; Liu T; Wang Y
    Sci Bull (Beijing); 2024 Apr; ():. PubMed ID: 38664095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease.
    Chatterjee P; Pedrini S; Ashton NJ; Tegg M; Goozee K; Singh AK; Karikari TK; Simrén J; Vanmechelen E; Armstrong NJ; Hone E; Asih PR; Taddei K; Doré V; Villemagne VL; Sohrabi HR; Zetterberg H; Masters CL; Blennow K; Martins RN
    Alzheimers Dement; 2022 Jun; 18(6):1141-1154. PubMed ID: 34494715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships among tau burden, atrophy, age, and naming in the aphasic variant of Alzheimer's disease.
    Martersteck A; Sridhar J; Coventry C; Weintraub S; Mesulam MM; Rogalski E
    Alzheimers Dement; 2021 Nov; 17(11):1788-1797. PubMed ID: 34494711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive decline as an outcome and marker of progression toward dementia, in early preventive trials.
    Mura T; Coley N; Amieva H; Berr C; Gabelle A; Ousset PJ; Vellas B; Andrieu S;
    Alzheimers Dement; 2022 Apr; 18(4):676-687. PubMed ID: 34482607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of common reference regions on regional tau patterns in cross-sectional and longitudinal [
    Young CB; Landau SM; Harrison TM; Poston KL; Mormino EC;
    Neuroimage; 2021 Nov; 243():118553. PubMed ID: 34487825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transition from mild cognitive impairment to normal cognition: Determining the predictors of reversion with multi-state Markov models.
    Sanz-Blasco R; Ruiz-Sánchez de León JM; Ávila-Villanueva M; Valentí-Soler M; Gómez-Ramírez J; Fernández-Blázquez MA
    Alzheimers Dement; 2022 Jun; 18(6):1177-1185. PubMed ID: 34482637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Why the cognitive "fountain of youth" may be upstream: Pathways to dementia risk and resilience through social connectedness.
    Perry BL; McConnell WR; Coleman ME; Roth AR; Peng S; Apostolova LG
    Alzheimers Dement; 2022 May; 18(5):934-941. PubMed ID: 34482619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease.
    Wightman DP; Jansen IE; Savage JE; Shadrin AA; Bahrami S; Holland D; Rongve A; Børte S; Winsvold BS; Drange OK; Martinsen AE; Skogholt AH; Willer C; Bråthen G; Bosnes I; Nielsen JB; Fritsche LG; Thomas LF; Pedersen LM; Gabrielsen ME; Johnsen MB; Meisingset TW; Zhou W; Proitsi P; Hodges A; Dobson R; Velayudhan L; Heilbron K; Auton A; ; Sealock JM; Davis LK; Pedersen NL; Reynolds CA; Karlsson IK; Magnusson S; Stefansson H; Thordardottir S; Jonsson PV; Snaedal J; Zettergren A; Skoog I; Kern S; Waern M; Zetterberg H; Blennow K; Stordal E; Hveem K; Zwart JA; Athanasiu L; Selnes P; Saltvedt I; Sando SB; Ulstein I; Djurovic S; Fladby T; Aarsland D; Selbæk G; Ripke S; Stefansson K; Andreassen OA; Posthuma D
    Nat Genet; 2021 Sep; 53(9):1276-1282. PubMed ID: 34493870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting progression and cognitive decline in amyloid-positive patients with Alzheimer's disease.
    Dansson HV; Stempfle L; Egilsdóttir H; Schliep A; Portelius E; Blennow K; Zetterberg H; Johansson FD;
    Alzheimers Res Ther; 2021 Sep; 13(1):151. PubMed ID: 34488882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dementia in Africa: Current evidence, knowledge gaps, and future directions.
    Akinyemi RO; Yaria J; Ojagbemi A; Guerchet M; Okubadejo N; Njamnshi AK; Sarfo FS; Akpalu A; Ogbole G; Ayantayo T; Adokonou T; Paddick SM; Ndetei D; Bosche J; Ayele B; Damas A; Coker M; Mbakile-Mahlanza L; Ranchod K; Bobrow K; Anazodo U; Damasceno A; Seshadri S; Pericak-Vance M; Lawlor B; Miller BL; Owolabi M; Baiyewu O; Walker R; Gureje O; Kalaria RN; Ogunniyi A;
    Alzheimers Dement; 2022 Apr; 18(4):790-809. PubMed ID: 34569714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of dementia in
    Ebenau JL; van der Lee SJ; Hulsman M; Tesi N; Jansen IE; Verberk IMW; van Leeuwenstijn M; Teunissen CE; Barkhof F; Prins ND; Scheltens P; Holstege H; van Berckel BNM; van der Flier WM
    Alzheimers Dement (Amst); 2021; 13(1):e12229. PubMed ID: 34541285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rates of longitudinal change in
    Phillips JS; Nitchie FJ; Da Re F; Olm CA; Cook PA; McMillan CT; Irwin DJ; Gee JC; Dubroff JG; Grossman M; Nasrallah IM;
    Alzheimers Dement; 2022 Jun; 18(6):1235-1247. PubMed ID: 34515411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood-based high sensitivity measurements of beta-amyloid and phosphorylated tau as biomarkers of Alzheimer's disease: a focused review on recent advances.
    Chong JR; Ashton NJ; Karikari TK; Tanaka T; Schöll M; Zetterberg H; Blennow K; Chen CP; Lai MKP
    J Neurol Neurosurg Psychiatry; 2021 Nov; 92(11):1231-1241. PubMed ID: 34510001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma antioxidants and risk of dementia in older adults.
    Koch M; Furtado JD; Cronjé HT; DeKosky ST; Fitzpatrick AL; Lopez OL; Kuller LH; Mukamal KJ; Jensen MK
    Alzheimers Dement (N Y); 2021; 7(1):e12208. PubMed ID: 34504943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting Symptom Onset in Sporadic Alzheimer Disease With Amyloid PET.
    Schindler SE; Li Y; Buckles VD; Gordon BA; Benzinger TLS; Wang G; Coble D; Klunk WE; Fagan AM; Holtzman DM; Bateman RJ; Morris JC; Xiong C
    Neurology; 2021 Nov; 97(18):e1823-e1834. PubMed ID: 34504028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.